Cargando...
Olaparib in the management of ovarian cancer
Alterations in the homologous repair pathway are thought to occur in 30%–50% of epithelial ovarian cancers. Cells deficient in homologous recombination rely on alternative pathways for DNA repair in order to survive, thereby providing a potential target for therapy. Olaparib, a poly(ADP-ribose) poly...
Gardado en:
| Publicado en: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4538690/ https://ncbi.nlm.nih.gov/pubmed/26309417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S62809 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|